Related Experiment Video
Updated: Mar 25, 2026

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
[Development of New Molecular EZH2 on Lung Cancer Invasion and Metastasis]
Hui Xia1, Changhai Yu1, Wen Zhang1
1Department of Thoracic-cardio Surgery, the First Affiliated Hospital of General Hospital of PLA, 100048 Beijing, China.
Abstract:
Lung cancer is a serious threat to human health malignancies upward trend in morbidity and mortality. It is hot topic to investigate the molecular mechanisms of lung cancer development and explore the new therapeutic targets. The underlying mechanism of EZH2 on lung cancer development will demonstrate the new pathway of lung cancer development, invasion and metastasis. The exploration and application of new targeted molecular will improve the survival rate and living quality of lung cancer patients in future.
Insights
This study investigates enhancer of zeste homolog 2 (EZH2) in lung cancer. Understanding EZH2
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Lung cancer presents a significant global health challenge with increasing incidence and mortality rates.
- Identifying novel molecular mechanisms and therapeutic targets is crucial for effective lung cancer treatment.
Purpose of the Study:
- To elucidate the role of enhancer of zeste homolog 2 (EZH2) in the development, invasion, and metastasis of lung cancer.
- To explore EZH2 as a potential therapeutic target for lung cancer.
Main Methods:
- The study focuses on the molecular mechanisms underlying EZH2's function in lung cancer.
- Investigative approaches include molecular biology techniques and potentially in vitro/in vivo models (details not provided in abstract).
Main Results:
- The research aims to demonstrate a novel pathway involving EZH2 in lung cancer progression.
- Findings are expected to highlight EZH2's contribution to invasion and metastasis.
Conclusions:
- Understanding EZH2's mechanism provides new insights into lung cancer development.
- Targeting EZH2 may offer a promising strategy to improve patient survival and quality of life.
More Related Videos
13:34A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
09:38Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
Published on: June 26, 2019
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Mitogens and the Cell Cycle